MAFAmbrisentan Tablet 5 mg, 10 mg
Treatment of adults with a confirmed diagnosis of WHO Functional Class II or III pulmonary arterial hypertension (PAH) who have one of the following PAH aetiologies:
• Idiopathic PAH
• Heritable or familial PAH
• PAH associated with connective tissue disease
• Anorexigen-induced PAH
• PAH associated with HIV infection